Special Issue


Clinical Practice (Therapy) Journal is an open-access, peer-reviewed academic journal offering an open forum for the worldwide dissemination of original and novel medical publications focused on the different aspects of effective clinical approaches to the treatment of diseases. The journal prioritizes the publication of manuscripts that can provide useful insights into the real time efficacy and persisting lacunae in the various various concepts, methods , and procedures used in the diagnosis and treatment of acute and chronic diseases. The journal serves as a bridge between the medical community and the general public by dispersing scientific developments in medical and clinical research and manuscripts that illustrate how these research advancements can change the currently followed medical procedures.

COVID-19 has caused a global crisis resulting from one of the most biggest pandemics in human history. This infectious disease has uprooted our lives, social relationships and work habits has turned out to be an unmissable opportunity to rethink our collaborative research and strive to drive attention to those who we care about most. The emergence of Corona Virus Disease 2019 (COVID-19) caused by the novel SARS-CoV-2 virus in Wuhan, China in December 2019, raised many challenges to clinical research. Even now, investigators, industry sponsors and institutional review boards/ethical committees struggle to maintain the safety of trial participants and researchers, while promoting the continuity of ongoing clinical studies.

The scope of this special issue encompass a broad range of topics including translational science research, genetics, immunology, nutrition, psychosocial research, epidemiology and multidisciplinary team approaches towards imparting quality healthcare services during post and pre COVID period. The journal also welcomes articles written by doctors, physicians and medical giants that present their personal perspectives in treating COVID-19 affected patients.

You may submit special issue article as an email attachment to [email protected]

Relevant Topics